RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY

The Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 15 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of the Vienna BioCenter (VBC), the IMP is embedded in one of Europe’s biggest life science hubs with 1600 employees.